Hypersensitivity Pneumonitis Induced by Nalidixic Acid

Michael Dan, Dan Aderka*, Marcel Topilsky, Ella Livni, Yoram Levo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

• Interstitial pneumonitis developed in a patient one week after therapy with nalidixic acid was initiated. The causal association between the drug and the lung disease is based on the temporal relationship, an increased eosinophil count in both peripheral blood and fluid obtained by bronchoalveolar lavage, a positive migration inhibitory factor test with nalidixic acid, and exclusion of other causes. This is, to the best of our knowledge, the first report of a pulmonary hypersensitivity reaction to nalidixic acid.

Original languageEnglish
Pages (from-to)1423-1424
Number of pages2
JournalArchives of Internal Medicine
Volume146
Issue number7
DOIs
StatePublished - Jul 1986
Externally publishedYes

Fingerprint

Dive into the research topics of 'Hypersensitivity Pneumonitis Induced by Nalidixic Acid'. Together they form a unique fingerprint.

Cite this